Compounds > idarubicin
Page last updated: 2024-08-23

idarubicin and medroxyprogesterone acetate

idarubicin has been researched along with medroxyprogesterone acetate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Avallone, L; d'Angelo, D; Florio, S; Galdiero, M; Iovane, G; Lombardi, P; Pagnini, G; Pagnini, U; Tortora, G1
Ciarcia, R; Crispino, L; D'Andrilli, G; de Matteis, A; Florio, S; Giordano, A; Kumar, C; Pacilio, C; Pagnini, U; Vacca, G1
Ciarcia, R; Crispino, L; d'Angelo, D; Florio, S; Pagnini, G1
Ciarcia, R; Crispino, L; Florio, S; Montagnaro, S; Pacelli, F; Pagnini, R1

Other Studies

5 other study(ies) available for idarubicin and medroxyprogesterone acetate

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Modulation of anthracycline activity in canine mammary tumour cells in vitro by medroxyprogesterone acetate.
    Research in veterinary science, 2000, Volume: 69, Issue:3

    Topics: Animals; Anthracyclines; Cell Survival; Dogs; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Female; Fluorescence Polarization; Idarubicin; Lipid Peroxidation; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Membrane Fluidity; Nitric Oxide; Tumor Cells, Cultured

2000
MPA increases idarubicin-induced apoptosis in chronic lymphatic leukaemia cells via caspase-3.
    Journal of cellular biochemistry, 2003, Jul-01, Volume: 89, Issue:4

    Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase Inhibitors; Caspases; Dogs; Drug Synergism; Enzyme Inhibitors; Fluorometry; Idarubicin; Isoenzymes; Leukemia, Lymphocytic, Chronic, B-Cell; Medroxyprogesterone Acetate; Nucleosomes; Propidium; Tumor Cells, Cultured

2003
Medroxyprogesterone acetate increases anthracycline-induced lipid peroxidation and membrane fluidity.
    Veterinary research communications, 2003, Volume: 27 Suppl 1

    Topics: Animals; Antibiotics, Antineoplastic; Dogs; Doxorubicin; Drug Synergism; Idarubicin; Leukocytes; Lipid Peroxidation; Medroxyprogesterone Acetate; Membrane Fluidity

2003
MPA inhibits idarubicin activity on Cu-Zn SOD and catalase.
    Veterinary research communications, 2004, Volume: 28 Suppl 1

    Topics: Animals; Antineoplastic Agents, Hormonal; Catalase; Idarubicin; Kinetics; Medroxyprogesterone Acetate; Rats; Superoxide Dismutase

2004